Related Experiment Video
Updated: Aug 16, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Giant cell arteritis: diagnosing and treating inflammatory disease in older adults
Syed S Azhar1, Rosa A Tang, E Ulysses Dorotheo
1Department of Family Medicine, University of Texas Medical Branch, Galveston, TX, USA.
Abstract:
Giant cell arteritis (GCA), also known as temporal arteritis, cranial arteritis, or granulomatous arteritis, is a systemic necrotizing vasculitis seen in patients typically over age 50. If untreated, GCA can cause permanent visual loss in one or both eyes in 13% to 50% of patients. Primary care physicians routinely see elderly patients with headaches and fatigue; these may be potential symptoms of GCA. C-reactive protein (CRP) in conjunction with erythrocyte sedimentation rate (ESR) has 97% specificity in diagnosing GCA. Temporal artery biopsy confirms the diagnosis in many cases. Early recognition and treatment of this potentially blinding condition is thus essential. Systemic steroids are the standard therapy for patients with a positive diagnosis of GCA, and in a high percentage of patients the treatment may extend for more than one year.
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Aneurysm III: Interprofessional Care
Myocarditis III: Medical Management
Peripheral Artery Disease III: Interprofessional Care
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Rheumatic Heart Disease IV: Nursing Management
